+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Diagnostics Market by Product Type, End User, Distribution Channel, Test Technology - Global Forecast to 2030- Product Image
Diabetes Diagnostics Market by Product Type, End User, Distribution Channel, Test Technology - Global Forecast to 2030- Product Image
Sale

Diabetes Diagnostics Market by Product Type, End User, Distribution Channel, Test Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887858
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The diabetes diagnostics market is experiencing pivotal transformation as technological innovation and evolving patient needs drive new standards in disease identification and management. Senior decision-makers must navigate heightened complexity—balancing product development, regulatory adaptation, and cross-sector collaborations—to secure competitive advantage in this fast-advancing landscape.

Market Snapshot: Diabetes Diagnostics Market Growth Outlook

The Diabetes Diagnostics Market grew from USD 21.91 billion in 2024 to USD 23.67 billion in 2025. It is expected to continue growing at a CAGR of 7.85%, reaching USD 34.50 billion by 2030. This sustained growth highlights robust global demand, continuous product innovation, and heightened focus on early detection and disease management across key geographies.

Scope & Segmentation

This report delivers a comprehensive assessment of the diabetes diagnostics sector, supported by multi-dimensional segmentation and regional analyses:

  • Product Types: Blood glucose meters (desktop, portable); continuous glucose monitoring (intermittent scanning, real-time); HbA1c test kits (lab-based, point-of-care); lancets (lancing devices, single-use); and test strips.
  • End Users: Diagnostic laboratories, home care settings, hospitals and clinics, research institutes.
  • Distribution Channels: Hospital pharmacies, online pharmacies (including e-commerce platforms and retailer websites), retail pharmacies, wholesale distributors.
  • Test Technologies: Invasive, minimally invasive, and noninvasive diagnostic methods.
  • Geographic Regions: Americas (including US, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (covering the UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (comprising China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Competitors: Roche Diagnostics International AG, Abbott Laboratories, LifeScan, Inc., Dexcom, Inc., Medtronic plc, Ascensia Diabetes Care Holdings AG, Nova Biomedical Corporation, Arkray, Inc., Nipro Corporation, AgaMatrix, Inc.

Key Takeaways for Strategic Decision-Makers

  • Digital health integration is advancing, linking devices with cloud-based platforms and mobile applications to supply real-time data for clinicians and patients.
  • Personalized medicine is increasingly adopted, with genetic profiling and biomarker analysis enabling more tailored diagnostic and treatment pathways.
  • Artificial intelligence and machine learning are elevating the performance of continuous glucose monitoring and point-of-care systems, enhancing clinical accuracy while streamlining workflows.
  • Market players are adapting to frequent regulatory changes, including expedited technology approvals and stricter safety standards, requiring flexible development strategies.
  • The focus on holistic care models is growing, integrating diagnostics with lifestyle management and behavioral support to address the broader needs of diabetes patients.
  • Distribution strategies are diversifying as online and subscription-based channels expand, making diagnostics more accessible across diverse geographies.

Tariff Impact: Market Adaptation Amid Changing Trade Policies

The imposition of US tariffs on key diabetes diagnostic imports in 2025 has introduced fresh operational challenges. Manufacturers are responding through supply chain diversification, including dual-sourcing and nearshoring, to reduce tariff exposure. The shift is also driving investment in domestic manufacturing as companies seek to strengthen logistics and ensure regulatory compliance. On the demand side, payer scrutiny is intensifying—greater emphasis on cost-effectiveness and proven outcomes is shaping procurement and influencing the adoption of integrated digital solutions. Agility in pricing and sourcing is crucial for sustaining margin and market share under evolving trade constraints.

Methodology & Data Sources

Analysis is grounded in a rigorous research approach: in-depth primary interviews with healthcare and industry experts, comprehensive secondary reviews of scientific literature, regulatory filings, company reports, and triangulation of proprietary and qualitative data. Ongoing validation through expert consultations ensures relevance and precision.

Why This Report Matters

  • Uncovers critical trends and disruptive technologies influencing product development, distribution, and patient engagement in the diabetes diagnostics market.
  • Offers actionable intelligence for refining business models, optimizing regional and global strategies, and navigating regulatory or trade-related shifts.
  • Supports effective investment decisions and partnership formation by detailing emerging opportunities and competitor approaches at category and geographic levels.

Conclusion

The diabetes diagnostics market is set for continued innovation and transformation, driven by digital advances, regulatory shifts, and expanding patient needs. Stakeholders prepared to adapt strategies, embrace new technologies, and respond to regional demands will strengthen their market position and deliver value as the sector evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diabetes Diagnostics Market, by Product Type
8.1. Introduction
8.2. Blood Glucose Meters
8.2.1. Desktop Meters
8.2.2. Portable Meters
8.3. Continuous Glucose Monitoring Systems
8.3.1. Intermittent Scanning Continuous Glucose Monitoring
8.3.2. Real-Time Continuous Glucose Monitoring
8.4. Hba1c Test Kits
8.4.1. Lab-Based
8.4.2. Point-Of-Care
8.5. Lancets
8.5.1. Lancing Devices
8.5.2. Single-Use Lancets
8.6. Test Strips
9. Diabetes Diagnostics Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Home Care Settings
9.4. Hospitals & Clinics
9.5. Research Institutes
10. Diabetes Diagnostics Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. E-Commerce Platforms
10.3.2. Retailer Websites
10.4. Retail Pharmacies
10.5. Wholesale Distributors
11. Diabetes Diagnostics Market, by Test Technology
11.1. Introduction
11.2. Invasive
11.3. Minimally Invasive
11.4. Noninvasive
12. Americas Diabetes Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Diabetes Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Diabetes Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Diagnostics International AG
15.3.2. Abbott Laboratories
15.3.3. LifeScan, Inc.
15.3.4. Dexcom, Inc.
15.3.5. Medtronic plc
15.3.6. Ascensia Diabetes Care Holdings AG
15.3.7. Nova Biomedical Corporation
15.3.8. Arkray, Inc.
15.3.9. Nipro Corporation
15.3.10. AgaMatrix, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DIABETES DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. DIABETES DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. DIABETES DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIABETES DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DESKTOP METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PORTABLE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REAL-TIME CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LAB-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY SINGLE-USE LANCETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAILER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 63. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 64. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 65. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 66. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 69. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 118. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 119. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 121. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 124. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 127. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 130. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 145. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 147. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 148. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 151. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 154. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 155. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 157. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 190. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 191. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 193. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 208. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 210. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 211. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 217. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 218. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 223. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 244. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 247. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 250. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 253. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 254. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 256. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 259. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 271. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 272. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 274. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 280. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 281. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 282. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 283. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 286. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 306. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 308. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 309. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 310. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 311. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 314. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 317. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 318. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2030 (USD MILLION)
TABLE 319. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2030 (USD MILLION)
TABLE 320. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 323. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2030 (USD MILLION)
TABLE 326. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 327. JAPAN DIABETE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Diabetes Diagnostics market report include:
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • LifeScan, Inc.
  • Dexcom, Inc.
  • Medtronic plc
  • Ascensia Diabetes Care Holdings AG
  • Nova Biomedical Corporation
  • Arkray, Inc.
  • Nipro Corporation
  • AgaMatrix, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.5 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Diabetes Diagnostics - Global Strategic Business Report - Product Image

Diabetes Diagnostics - Global Strategic Business Report

  • Report
  • 609 Pages
  • Global
From
Diabetes Diagnostics Global Market Report 2025 - Product Image

Diabetes Diagnostics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Disposable Diabetes Lancets Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Disposable Diabetes Lancets Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Insulin Patch Pumps Market by Product Type, Diabetes Type, Patient Age Group, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Insulin Patch Pumps Market by Product Type, Diabetes Type, Patient Age Group, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Automated Insulin Delivery System Market by Product Type, Component, Insulin Type, End User, Distribution Channel, Technology, Diabetes Type, Care Setting - Global Forecast to 2030 - Product Image

Automated Insulin Delivery System Market by Product Type, Component, Insulin Type, End User, Distribution Channel, Technology, Diabetes Type, Care Setting - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From

About the Diabetes Diagnostics Market

The Diabetes Diagnostics market is a subset of the Diagnostics industry, which focuses on the detection and diagnosis of diabetes. This market includes products and services used to detect and diagnose diabetes, as well as to monitor and manage the disease. These products and services include glucose meters, test strips, lancets, insulin pumps, continuous glucose monitoring systems, and other diabetes management tools. The Diabetes Diagnostics market is driven by the increasing prevalence of diabetes, the growing awareness of the disease, and the increasing demand for better management of the disease. Additionally, technological advancements in diabetes diagnostics have enabled the development of more accurate and efficient diagnostic tools. Some of the major companies in the Diabetes Diagnostics market include Abbott Laboratories, Roche Diagnostics, Johnson & Johnson, Bayer AG, and Medtronic. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.